Cytori Therapeutics, Inc. (CYTX) Reports In-Line Q1 Loss of 16c/Share
Tweet Send to a FriendGet Alerts CYTX Hot Sheet
Price: $2.55 +1.59%
Revenue Growth %: +251.0%
Financial Fact:
Gross profit: 636K
Today's EPS Names:
BOSC, GASS, AAP, More
Revenue Growth %: +251.0%
Financial Fact:
Gross profit: 636K
Today's EPS Names:
BOSC, GASS, AAP, More
Trade CYTX Now!
Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q1 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $1.48 million, versus $1.36 million reported last year.
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Signet Jewelers (SIG) Tops Q1 EPS Views; Comsp Up 6.4%; Guides Q2 EPS
- Patterson Companies, Inc. (PDCO) Reports In-Line Q4 EPS; Guides In-Line
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
